Biohaven Spotlights BHV-1420 at ASN Kidney Week 2026
Biohaven presented BHV-1420, a novel TRAP degrader designed to selectively remove autoantibodies that drive membranous nephropathy.
Biohaven presented BHV-1420, a novel TRAP degrader designed to selectively remove autoantibodies that drive membranous nephropathy.